Effect of obesity and feeding on the growth hormone (GH) response to the GH secretagogue L-692,429 in young men

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 4, 1997, Pages 1154-1159

  Kirk, Susan E ^a   Gertz, Barry J ^c   Schneider, Stephen H ^b   Hartman, Mark L ^a   Pezzoli, Suzan S ^a   Wittreich, Johanna M ^c   Krupa, David A ^c   Seibold, James R ^b   Thorner, Michael O ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 3 METHYL N [2,3,4,5 TETRAHYDRO 2 OXO 1 [[2' (1H TETRAZOL 5 YL) 1,1' BIPHENYL 4 YL]METHYL] 1H 1 BENZAZEPIN 3 YL]BUTANAMIDE; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; PLACEBO; PROLACTIN; SERMORELIN;

ADULT; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DYSPNEA; FEEDING; FLUSHING; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; BENZAZEPINES; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EATING; HUMAN GROWTH HORMONE; HUMANS; MALE; OBESITY; REFERENCE VALUES; TETRAZOLES;

EID: 0030941682     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.4.1154     Document Type: Article

References (38)

1. Thorner MO, Vance ML, Horvath E, Kovacs K. 1991 The anterior pituitary. In: Wilson JD, Foster DW, eds. Williams textbook of endocrinology, 7th ed. Philadelphia: Saunders; 221-310.
2. Yamashita S, Melmed S. 1986 Insulin-like growth factor 1 action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels. Endocrinology. 118:176-182.
3. Hartman ML, Clayton PE, Johnson ML, et al. 1993 A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest. 91:2453-2462.
4. Hartman ML, Thorner MO. Fasting-induced enhancement of pulsatile growth hormone secretion is rapidly abolished by refeeding. Proc of the 72nd Annual Meet of The Endocr Soc. 1990; 73.
5. Veldhuis JD, Iranmanesh A, Ho KKY, Waters MJ, Johnson ML, Lizarralde G. 1991 Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotrophism of obesity in man. J Clin Endocrinol Metab. 72:51-59.
6. Williams T, Berelowitz M, Joffe SN, et al. 1984 Impaired growth hormone responses to growth hormone-releasing factor in obesity: a pituitary defect reversed with weight reduction. N Engl J Med. 311:1403-1407.
7. Ghigo E, Procipio M, Boffano GM, et al. 1992 Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity. Metabolism. 41:560-563.
8. Kelijman M, Frohman LA. 1988 Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects. J Clin Endocrinol Metab. 66:489-494.
9. Bowers CY, Sartor AO, Reynolds GA, Badger TM. 1991 On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology. 128:2027-2035.
10. Pong S-S, Chaung L-YP, Dean DC, Nargund RP, Patchett AA, Smith RG. 1996 Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol. 10:57-61.
11. Howard AD, Feighner SD, Cully DF, et al. 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 273:974-977.
12. Bowers CY, Momany FA, Reynolds GA, Hong A. 1984 On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 114:1537-1545.
13. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO. 1990 Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab. 70:975-982.
14. Guillame V, Magnan E, Cataldi M, et al. 1994 Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology. 135:1073-1076.
15. Hartman ML, Farello G, Pezzoli SS, Thorner MO. 1992 Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men. J Clin Endocrinol Metab. 74:1378-1384.
16. Smith RG, Cheng K, Schoen WR, et al. 1993 A nonpeptidyl growth hormone secretagogue. Science. 260:1640-1643.
17. Gertz BJ, Barrett JS, Eisenhandler R, et al. 1993 Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6. J Clin Endocrinol Metab. 77:1393-1397.
18. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP. 1981 Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest. 67:1361-1369.
19. Aloi JA, Gertz BJ, Hartman ML, et al. 1994 Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects. J Clin Endocrinol Metab. 79:943-949.
20. Gertz BJ, Sciberras DG, Yogendran L, et al. 1994 L-692,429, a nonpeptide growth hormone (GH) secretagogue, reverses glucocorticoid suppression of GH secretion. J Clin Endocrinol Metab. 79:745-749.
21. Vance ML, Borges JL, Kaiser DL, et al. 1984 Human pancreatic tumor growth hormone-releasing factor: dose relationships in normal man. J Clin Endocrinol Metab. 58:838-844.
22. Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD, Thorner MO. 1994 Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab. 78:1312-1319.
23. Kopelman PG, Noonan K. 1986 Growth hormone response to low dose intravenous injections of growth hormone releasing factor in obese and normal weight women. Clin Endocrinol (Oxf). 24:157-164.
24. Momany FA, Bowers CY, Reynolds GA, Chang D, Hong A, Newlander K. 1981 Design, synthesis, and biological activity of peptides which release growth hormone in vitro. Endocrinology. 108:31-39.
25. Codd EE, Shu AYL, Walker RF. 1989 Binding of a growth hormone releasing hexpeptide to specific hypothalamic and pituitary binding sites. Neuropharmacology. 28:1139-1144.
26. Chen C, Wu D, Clarke IJ. 1996 Signal transduction systems employed by synthetic GH-releasing peptides in somatotrophs. J Endocrinol. 148:381-386.
27. Bilezikjian LM, Vale WW. 1983 Simulation of 3′ 5′-monophosphate production by growth hormone-releasing factor and its inhibition by somatostatin in anterior pituitary cells in vitro. Endocrinology. 113:1726-1731.
28. Adams EF, Petersen B, Lei T, Buchfelder M, Fahlbusch R. 1995 The growth hormone secretagogue, L-692,429, induces phosphatidylinositol hydrolysis and hormone secretion by human pituitary tumors. Biochem Biophys Res Commun. 208:555-561.
29. Cheng K, Chan WW-S, Butler G, et al. 1993 Stimulation of growth hormone release from rat primary pituitary cells by L-692,429, a novel non-peptidyl GH secretagogue. Endocrinology. 132:2729-2731.
30. Clemmons DR, Underwood LE. 1991 Nutritional regulation of IGF-I and IGF-I binding proteins. Annu Rev Nutr. 11:393-412.
31. Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE, Orskov H. 1995 Free insulin-like growth factors in human obesity. Metabolism. 44(Suppl 4):37-44.
32. Yamashita S, Melmed S. 1986 Insulin-like growth factor I action on rat interior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels. Endocrinology. 118:176-182.
33. Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL. 1981 Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science. 212:1279-1281.
34. Harel Z, Tannebaum GS. 1992 Synergistic interaction between insulin-like growth factors-I and -II in central regulation of pulsatile growth hormone secretion. Endocrinology. 131:758-764.
35. Vance ML. 1990 Growth hormone for the elderly? N Engl J Med. 323:52-54.
36. Rudman D, Feller AG, Nagraj HS, et al. 1990 Effects of human growth hormone in men over 60 years old. N Engl J Med. 323:1-6.
37. Cuneo RC, Salomon F, Wiles CM, Hesp R, Sonksen PH. 1991 Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. J Appl Physiol. 70:695-700.
38. Nass R, Huber RM, Klauss V, Muller OA, Schopohl J, Strasburger CJ. 1995 Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. J Clin Endocrinol Metab. 80:532-537.